CD8A and rectal cancer: In summary, neoadjuvant chemoradiotherapy with infusional gemcitabine demonstrates durable survival outcomes and significant enhancement of immune cell infiltration, particularly CD8+ T cells and PD-L1+ lymphocytes, in locally advanced rectal cancer.